pharma · Primary Biliary Cholangitis · Pyoderma Gangrenosum
PHARMACEUTICAL ENTERPRISES
Arena Pharmaceutical Enterprises Limited
Arena Pharmaceutical Enterprises is a pharma organization headquartered in GB. Primary therapeutic focus areas include Primary Biliary Cholangitis, Pyoderma Gangrenosum, Ulcerative Colitis. NovaPharmaNews links 3 clinica
Cape Town, GB HQ
1984 Founded
15 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Cape Town, GB
- Founded
- 1984
- Employees
- 15
- Programs
- 3
- Drugs
- 1
- Patents
- 0
Etrasimod
Phase 2 · small molecule · Ulcerative Colitis
Etrasimod for Ulcerative Colitis is a Phase 2 program (small_molecule) at Arena Pharmaceutical Enterprises Limited with 1 ClinicalTrials.gov record(s).
Internal code APD334-005
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Arena Pharmaceutical Enterprises Limited
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Ulcerative Colitis
- Status
- completed
- Trials
- 1